UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1436) 1436
Newsletter (23) 23
Publication (8) 8
Book Chapter (6) 6
Magazine Article (5) 5
Newspaper Article (2) 2
Reference (2) 2
Report (2) 2
Web Resource (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1237) 1237
male (928) 928
female (820) 820
middle aged (745) 745
atenolol - therapeutic use (741) 741
science & technology (740) 740
life sciences & biomedicine (715) 715
atenolol - adverse effects (704) 704
hypertension - drug therapy (645) 645
adult (570) 570
atenolol (545) 545
aged (534) 534
blood pressure - drug effects (391) 391
double-blind method (370) 370
hypertension (315) 315
antihypertensive agents - therapeutic use (283) 283
cardiovascular system & cardiology (282) 282
adrenergic beta-antagonists - therapeutic use (269) 269
heart rate - drug effects (263) 263
abridged index medicus (247) 247
atenolol - administration & dosage (244) 244
adrenergic beta-antagonists - adverse effects (225) 225
drug therapy, combination (220) 220
antihypertensive agents - adverse effects (207) 207
hypertension - physiopathology (203) 203
atenolol - pharmacology (186) 186
pharmacology & pharmacy (185) 185
cardiac & cardiovascular systems (173) 173
treatment outcome (172) 172
clinical trials as topic (156) 156
blood pressure (129) 129
hypertension - complications (121) 121
peripheral vascular disease (119) 119
adolescent (115) 115
animals (112) 112
time factors (111) 111
drug therapy (110) 110
random allocation (108) 108
general & internal medicine (103) 103
electrocardiography (102) 102
risk factors (101) 101
dose-response relationship, drug (99) 99
medicine, general & internal (99) 99
propanolamines - therapeutic use (91) 91
adrenergic beta-antagonists - pharmacology (82) 82
aged, 80 and over (80) 80
angina pectoris - drug therapy (80) 80
follow-up studies (75) 75
propranolol - adverse effects (75) 75
randomized controlled trials as topic (74) 74
propanolamines - adverse effects (73) 73
adrenergic beta-antagonists - administration & dosage (72) 72
antihypertensive agents - administration & dosage (70) 70
prospective studies (69) 69
metoprolol - adverse effects (67) 67
research article (67) 67
losartan - therapeutic use (66) 66
care and treatment (65) 65
nifedipine - adverse effects (65) 65
hemodynamics - drug effects (61) 61
research (60) 60
analysis (59) 59
hydrochlorothiazide - therapeutic use (57) 57
metoprolol (57) 57
angiotensin-converting enzyme inhibitors - therapeutic use (56) 56
calcium channel blockers - therapeutic use (56) 56
cardiovascular disease (56) 56
exercise test (56) 56
nifedipine - therapeutic use (56) 56
drug administration schedule (55) 55
drugs (55) 55
antihypertensive agents - pharmacology (54) 54
hypertension - blood (54) 54
metoprolol - therapeutic use (53) 53
heart rate (52) 52
rats (51) 51
pregnancy (50) 50
propranolol (49) 49
propranolol - therapeutic use (49) 49
cardiology (48) 48
hydrochlorothiazide (47) 47
hydrochlorothiazide - adverse effects (47) 47
medicine & public health (47) 47
delayed-action preparations (45) 45
drug combinations (44) 44
lipids - blood (44) 44
administration, oral (43) 43
diabetes (43) 43
dosage and administration (43) 43
mortality (43) 43
cardiovascular diseases (42) 42
health aspects (42) 42
enalapril - therapeutic use (41) 41
angina pectoris (40) 40
antihypertensive drugs (40) 40
atenolol - pharmacokinetics (40) 40
diuretics (40) 40
drug interactions (40) 40
nebivolol (39) 39
angiotensin-converting enzyme inhibitors - adverse effects (38) 38
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1391) 1391
German (26) 26
French (21) 21
Italian (16) 16
Spanish (14) 14
Russian (9) 9
Chinese (7) 7
Japanese (6) 6
Portuguese (4) 4
Czech (3) 3
Dutch (3) 3
Polish (3) 3
Norwegian (2) 2
Finnish (1) 1
Hebrew (1) 1
Hungarian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 09/2005, Volume 366, Issue 9489, pp. 895 - 906
.... Our aim, therefore, was to compare the effect on non-fatal myocardial infarction and fatal CHD of combinations of atenolol with a thiazide versus amlodipine with perindopril... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Calcium Channel Blockers - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Bendroflumethiazide - administration & dosage | Hypertension - drug therapy | Male | Perindopril - administration & dosage | Sodium Chloride Symporter Inhibitors - administration & dosage | Diuretics | Adrenergic beta-Antagonists - adverse effects | Adult | Female | Blood Pressure - drug effects | Atenolol - administration & dosage | Drug Therapy, Combination | Amlodipine - administration & dosage | Adrenergic beta-Antagonists - administration & dosage | Risk Factors | Amlodipine - adverse effects | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Antihypertensive Agents - adverse effects | Coronary Disease - prevention & control | Calcium Channel Blockers - administration & dosage | Atenolol - adverse effects | Hypertension - complications | Aged | Hypertension | Antihypertensive drugs | Evaluation | Dosage and administration | Drug therapy | Prevention | Drug therapy, Combination | Health aspects | Coronary heart disease | Risk factors | Studies | Drugs | Cardiovascular disease | Medical treatment | Myocardial infarction | Heart attacks | Antihypertensives | Clinical trials | Family medical history | Evidence-based medicine | Blood | Randomization | Motivation | Blood pressure | Heart diseases | Antihypertensive agents | Cerebral infarction | Stroke | Fasting | Mortality | Diabetes mellitus | Health risks | Triglycerides | Metabolism | Risk analysis | Atenolol | Patients | Coronary artery disease | Cholesterol | Heart rate | Infarction | Diabetes | Cardiovascular diseases | Health risk assessment | Potassium | Index Medicus | Abridged Index Medicus | Amlodipine/administration & dosage/adverse effects | Bendroflumethiazide/administration & dosage | Cardiovascular Diseases/prevention & control | Perindopril/administration & dosage | MEDICIN OCH HÄLSOVETENSKAP | Atenolol/administration & dosage/adverse effects | Combination | Antihypertensive Agents/administration & dosage/adverse effects | Angiotensin-Converting Enzyme Inhibitors/administration & dosage | MEDICAL AND HEALTH SCIENCES | Coronary Disease/prevention & control | Drug Therapy | Adrenergic beta-Antagonists/administration & dosage/adverse effects | Blood Pressure/drug effects | Hypertension/complications/drug therapy | Calcium Channel Blockers/administration & dosage/adverse effects | Sodium Chloride Symporter Inhibitors/administration & dosage
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2014, Volume 371, Issue 22, pp. 2061 - 2071
Journal Article
Hypertension (Dallas, Tex. 1979), ISSN 1524-4563, 12/2002, Volume 40, Issue 6, pp. 897 - 902
Journal Article
Journal Article
Journal Article
Circulation Cardiovascular quality and outcomes, ISSN 1941-7713, 07/2012, Volume 5, Issue 4, pp. 463 - 471
.... We examined the incremental effects of 2 (full dose) plus K+ supplementation versus single polycap (low dose... 
Cardiovascular disease | Lipids | Blood pressure | Risk factors | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Tablets | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Hypertension - drug therapy | Male | Ramipril - administration & dosage | Polypharmacy | Time Factors | Atenolol - administration & dosage | Platelet Aggregation Inhibitors - adverse effects | Cardiovascular Diseases - etiology | Cardiovascular Diseases - physiopathology | Risk Assessment | Administration, Oral | Simvastatin - administration & dosage | Risk Factors | Biomarkers - blood | Antihypertensive Agents - adverse effects | Hypertension - metabolism | India | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Analysis of Variance | Potassium - urine | Creatinine - blood | Hypercholesterolemia - complications | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Biomarkers - urine | Antihypertensive Agents - administration & dosage | Hypercholesterolemia - drug therapy | Aspirin - administration & dosage | Dose-Response Relationship, Drug | Heart Rate - drug effects | Capsules | Platelet Aggregation Inhibitors - administration & dosage | Cholesterol, LDL - blood | Female | Blood Pressure - drug effects | Dietary Supplements - adverse effects | Cardiovascular Diseases - metabolism | Double-Blind Method | Treatment Outcome | Hydrochlorothiazide - administration & dosage | Hypertension - physiopathology | Potassium - adverse effects | Potassium - administration & dosage | Hypertension - complications | Potassium - blood | Aged | Hypercholesterolemia - metabolism | Drug Combinations | Index Medicus
Journal Article
Pharmacotherapy, ISSN 0277-0008, 11/2014, Volume 34, Issue 11, pp. 1132 - 1140
Journal Article
American Journal of Cardiovascular Drugs, ISSN 1175-3277, 04/2010, Volume 10, Issue 2, pp. 95 - 103
Background The Polycap™ (polypill; aspirin [acetylsalicylic acid], ramipril, simvastatin, atenolol, and hydrochlorothiazide) was found to be safe and effective... 
Drug-interactions | Ramipril, pharmacokinetics | Aspirin, pharmacokinetics | Hydrochlorothiazide, pharmacokinetics | Hydrochlorothiazide/atenolol/ramipril/simvastatin/aspirin, pharmacokinetics | Salicylic-acid, pharmacokinetics | Atenolol, pharmacokinetics | Risk-factors | Hydrochlorothiazide/atenolol/ramipril/simvastatin/aspirin, drug interactions | Simvastatin, pharmacokinetics | Cardiovascular-disorders, treatment | Pharmacotherapy | Medicine & Public Health | Cardiology | Pharmacology/Toxicology | Cardiac & Cardiovascular Systems | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Hydrochlorothiazide - pharmacokinetics | Simvastatin - adverse effects | Area Under Curve | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Aspirin - pharmacokinetics | Biological Availability | Male | Aspirin - administration & dosage | Ramipril - administration & dosage | Young Adult | Capsules | Drug Interactions | Aspirin - adverse effects | Atenolol - pharmacokinetics | Platelet Aggregation Inhibitors - administration & dosage | Adult | Platelet Aggregation Inhibitors - pharmacokinetics | Atenolol - administration & dosage | Ramipril - adverse effects | Tandem Mass Spectrometry - methods | Platelet Aggregation Inhibitors - adverse effects | Hydrochlorothiazide - adverse effects | Cardiovascular Diseases - etiology | Hypolipidemic Agents - adverse effects | Administration, Oral | Simvastatin - administration & dosage | Risk Factors | Ramipril - pharmacokinetics | Hydrochlorothiazide - administration & dosage | Antihypertensive Agents - pharmacokinetics | Simvastatin - pharmacokinetics | Antihypertensive Agents - adverse effects | Cross-Over Studies | Adolescent | Hypolipidemic Agents - administration & dosage | Atenolol - adverse effects | Chromatography, Liquid - methods | Hypolipidemic Agents - pharmacokinetics | Drug Combinations | Prevention | Complications and side effects | Drug interactions | Dosage and administration | Research | Cardiovascular diseases | Risk factors | Cardiovascular agents | Index Medicus
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 01/2017, Volume 2017, Issue 1, pp. CD002003 - CD002003
Journal Article